Latest Schedule 13D activist filings

SMX (Security Matters) Public Limited Company's Chairman and CEO, Haggai Alon, has disclosed a 16.24% beneficial ownership stake in the company, primarily through vested restricted stock units from the 2022 Incentive Equity Plan.

TPG Auriga has acquired a 12.6% beneficial ownership stake in Achieve Life Sciences through a private placement transaction.

CEO Marvin Slosman files a Schedule 13D reporting beneficial ownership of 5.18% of InspireMD, Inc. common stock.

Perceptive Advisors LLC reported an increased beneficial ownership of 12.6% in MeiraGTx Holdings plc following a recent share purchase.

Major shareholders L6 Holdings and Pinetree Capital have entered into voting agreements to support the acquisition of TruBridge, Inc. by Inventurus Knowledge Solutions.

AE Industrial Partners and affiliates sold 21.37 million shares of Redwire Corp at $10.85 per share.

Cankut and Esra Unluaslan Durgun reported the contribution of 10.8 million Class A shares to the Oktem Family Fund while maintaining voting and dispositive control.

Major shareholder Hang Muk Shin reports an 11.89% stake and raises concerns over potential unfair related-party transactions.

Ms. Kuo Fu-Feng and associated entities disclose a 33.34% beneficial ownership stake in Jyong Biotech Ltd.

Paul R. Taylor has acquired a significant beneficial ownership in Visium Technologies, Inc. as part of a strategic acquisition and leadership transition.

Director Robert Toth has filed a Schedule 13D, reporting beneficial ownership of 99,254 shares, or 5.1%, of Mannatech, Inc. common stock, acquired through director compensation.

Bradley & Daytona Railway & Land Co. LLC files Amendment No. 2 to its Schedule 13D regarding Power REIT's Series A Cumulative Redeemable Perpetual Preferred Stock.

Bradley & Daytona Railway and Land Co. LLC has increased its beneficial ownership of Power REIT's Series A Preferred Stock to 6.14%, acquiring additional shares between March and April 2026.

Two Seas Capital LP has disclosed a reduction in its beneficial ownership of Core Scientific, Inc. to below the 5% threshold.

OrbiMed Advisors reports a change in beneficial ownership of Prelude Therapeutics following a recent public offering.

BFI Co., LLC and Jack C. Bendheim disclosed a series of market sales of Phibro Animal Health Class A Common Stock.

Mill Road Capital III, L.P. has increased its beneficial ownership in Mistras Group, Inc. to approximately 5.9% through open market purchases and put option assignments.

WE-INN LLC has reduced its stake in Innventure, Inc. below 5%, marking the final amendment to its Schedule 13D filing.

TDR Capital and affiliates completed the sale of 8.05 million shares of Target Hospitality Corp. at $13.265 per share.

Saba Capital Management has increased its beneficial ownership in The Mexico Fund, Inc. to 13.07% of outstanding common shares.

Vladimir and Angelica Galkin have reported a 10% beneficial ownership stake in JetBlue Airways Corporation, signaling potential interest in board representation.

Laird Superfood has finalized the acquisition of Terrasoul Superfoods for $48 million, funded by a $60 million preferred stock issuance.

Rezolve AI reports significant share acquisitions by DBLP Sea Cow Limited and a new share issuance for services rendered.

Ocho Investments LLC and Andris Upitis have entered into a voting and support agreement to facilitate the acquisition of TruBridge, Inc. by Inventurus Knowledge Solutions.

RA Capital Management acquired 3,888,888 shares of Acrivon Therapeutics in an at-the-market offering for approximately $7 million.

Navitas Semiconductor director Ranbir Singh expresses concerns over board tenure, expertise, and capital raises, signaling potential director nominations.

Several Gabelli-affiliated entities have filed an amended Schedule 13D, reporting a combined beneficial ownership of 11.75% in Nathans Famous, Inc. following recent trading activity.

CalEthos Inc. has entered into a significant financing agreement with SFO IDF LLC, securing a $15 million loan and restructuring existing debt, alongside a joint venture for a data center campus.

Mat Ishbia and SFS Holding Corp. have filed an amendment to their Schedule 13D, reporting on their beneficial ownership of UWM Holdings Corporation's Class A Common Stock and detailing sales under a 10b5-1 trading plan.

Redmile Group, LLC has completed an internal reorganization of its holdings in Fate Therapeutics, shifting assets to specialized subsidiaries while maintaining a 14.9% aggregate stake.